Pharmacokinetic Drug–Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1918
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pharmacokinetic Drug–Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer ; volume:42 ; number:8 ; day:16 ; month:7 ; year:2022 ; pages:679-692 ; date:8.2022
Clinical drug investigation ; 42, Heft 8 (16.7.2022), 679-692, 8.2022
- Urheber
-
Li, Chao
Horton, Janet K.
Sale, Mark
Curd, Laura
Goti, Vineet
Tao, Wenli
Beelen, Andrew
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40261-022-01179-x
- URN
-
urn:nbn:de:101:1-2022101517045917838281
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Chao
- Horton, Janet K.
- Sale, Mark
- Curd, Laura
- Goti, Vineet
- Tao, Wenli
- Beelen, Andrew
- SpringerLink (Online service)
Ähnliche Objekte (12)
Midazolam Microdosing and Population Pharmacokinetic Modelling to Assess CYP3A Drug-Drug Interactions in Early Clinical Development
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
Modelling and simulation techniques to investigate pharmacokinetics, pharmacodynamics, and drug-drug interactions
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
Multi-view feature representation and fusion for drug-drug interactions prediction
Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders
Targeting continuity of care and polypharmacy to reduce drug–drug interaction
A Review of Daclatasvir Drug–Drug Interactions
Midazolam Microdosing and Population Pharmacokinetic Modelling to Assess CYP3A Drug-Drug Interactions in Early Clinical Development
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
Modelling and simulation techniques to investigate pharmacokinetics, pharmacodynamics, and drug-drug interactions
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
Multi-view feature representation and fusion for drug-drug interactions prediction
Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders
Targeting continuity of care and polypharmacy to reduce drug–drug interaction
A Review of Daclatasvir Drug–Drug Interactions
Midazolam Microdosing and Population Pharmacokinetic Modelling to Assess CYP3A Drug-Drug Interactions in Early Clinical Development
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
Modelling and simulation techniques to investigate pharmacokinetics, pharmacodynamics, and drug-drug interactions
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
Multi-view feature representation and fusion for drug-drug interactions prediction
Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders
Targeting continuity of care and polypharmacy to reduce drug–drug interaction